Page 39 - IJSA, Vol. 6, No 1, 2023
P. 39
International Journal of Science Annals, Vol. 6, No. 1, 2023
рrint ISSN: 2617-2682; online ISSN: 2707-3637; DOI:10.26697/ijsa
metabolism. Furthermore, the Apo B100/ Apo A1 ratio Chobanian, A. V., Bakris, G. L., Black, H. R.,
may be used as a complementary marker for the Cushman, W. C., Green, L. A., Izzo, J. L.,
prediction of the risk of cardiovascular disease in Jones, D. W., Materson, B. J., Oparil, S.,
essential hypertension subjects. Wright, J. T., & Roccella, E. J. (2003). The
Prospects for further research include establishing a seventh report of the Joint National Committee on
causal relationship between dyslipidemia and prevention, detection, evaluation, and treatment
hypertension; identifying changes in the lipid profile of high blood pressure: the JNC 7 report. JAMA,
caused by diet, physical activity, medications, or other 289(19), 2560–2572.
influences; and determining the relationship of lipid https://doi.org/10.1001/jama.289.19.2560
parameters and apolipoproteins with other cardiovascular Ferreira, I., van de Laar, R. J., Prins, M. H.,
risk factors. Twisk, J. W., & Stehouwer, C. D. (2012). Carotid
stiffness in young adults: A life-course analysis of
Ethical Approval its early determinants: the Amsterdam growth and
Institutional Ethical Committee approval was obtained health longitudinal study. Hypertension, 59(1),
from the institution (Reference No: IEC/MC/2020/459, 54–61.
dated 08/01/2021). https://doi.org/10.1161/HYPERTENSIONAHA.
110.156109
Funding Source Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M.,
This research did not receive any outside funding or Biryukov, S., Marczak, L., Alexander, L.,
support. Estep, K., Hassen Abate, K., Akinyemiju, T. F.,
Ali, R., Alvis-Guzman, N., Azzopardi, P.,
References Banerjee, A., Bärnighausen, T., Basu, A.,
Albucher, J. F., Ferrieres, J., Ruidavets, J. B., Guiraud- Bekele, T., Bennett, D. A., Biadgilign, S., Catalá-
Chaumeil, B., Perret, B. P., & Chollet, F. (2000). López, F., … Murray, C. J. (2017). Global burden
Serum lipids in young patients with ischaemic of hypertension and systolic blood pressure of at
stroke: A case-control study. Journal of least 110 to 115 mm Hg, 1990-2015. JAMA,
Neurology, Neurosurgery, and Psychiatry, 69(1), 317(2), 165–182.
29–33. https://doi.org/10.1136/jnnp.69.1.29 https://doi.org/10.1001/jama.2016.19043
AlGhatrif, M., Strait, J. B., Morrell, C. H., Canepa, M., Friedewald, W. T., Levy, R. I., & Fredrickson, D. S.
Wright, J., Elango, P., Scuteri, A., Najjar, S. S., (1972). Estimation of the concentration of low-
Ferrucci, L., & Lakatta, E. G. (2013). density lipoprotein cholesterol in plasma, without
Longitudinal trajectories of arterial stiffness and use of the preparative ultracentrifuge. Clinical
the role of blood pressure: The Baltimore Chemistry, 18(6), 499–502.
longitudinal study of aging. Hypertension, 62(5), https://doi.org/10.1093/clinchem/18.6.499
934–941. Gotto, A. M. (2005). Evolving concepts of dyslipidemia,
https://doi.org/10.1161/HYPERTENSIONAHA. atherosclerosis, and cardiovascular disease: The
113.01445 Louis F. Bishop lecture. Journal of the American
Anchala, R., Kannuri, N. K., Pant, H., Khan, H., College of Cardiology, 46(7), 1219–1224.
Franco, O. H., Di Angelantonio, E., & https://doi.org/10.1016/j.jacc.2005.06.059
Prabhakaran, D. (2014). Hypertension in India: a Haidari, M., Moghadam, M., Chinicar, M.,
systematic review and meta-analysis of Ahmadieh, A., & Doosti, M. (2001).
prevalence, awareness, and control of Apolipoprotein B as the best predictor of coronary
hypertension. Journal of Hypertension, 32(6), artery disease in Iranian normolipidemic patients.
1170–1177. Clinical Biochemistry, 34(2), 149–155.
https://doi.org/10.1097/HJH.0000000000000146 https://doi.org/10.1016/s0009-9120(01)00192-8
Barter, P. J., Nicholls, S., Rye, K. A., Halperin, R. O., Sesso, H. D., Ma, J., Buring, J. E.,
Anantharamaiah, G. M., Navab, M., & Stampfer, M. J., & Gaziano, J. M. (2006).
Fogelman, A. M. (2004). Antiinflammatory Dyslipidemia and the risk of incident
properties of HDL. Circulation Research, 95(8), hypertension in men. Hypertension, 47(1), 45–50.
764–772. https://doi.org/10.1161/01.HYP.0000196306.42418.0e
https://doi.org/10.1161/01.RES.0000146094.59640.13 Harvey, J. M., & Beevers, D. G. (1990). Biochemical
Bhavani, B. A., Padma, T., Sastry, B. K., & investigation of hypertension. Annals of Clinical
Reddy, N. K. (2003). Plasma lipoprotein (a) Biochemistry, 27(4), 287–296.
levels in patients with untreated essential https://doi.org/10.1177/000456329002700403
hypertension. Indian Journal of Human Genetics, Hausmann, D., Johnson, J. A., Sudhir, K.,
9(2), 65–68. https://www.ijhg.com/article-0971- Mullen, W. L., Friedrich, G., Fitzgerald, P. J.,
6866-2003-9-2-65-68-bhavani/ Chou, T. M., Ports, T. A., Kane, J. P.,
Carmena, R., Duriez, P., & Fruchart, J. C. (2004). Malloy, M. J., & Yock, P. G. (1996).
Atherogenic lipoprotein particles in Angiographically silent atherosclerosis detected
atherosclerosis. Circulation, 109(23 Suppl. 1), by intravascular ultrasound in patients with
III2–III7. familial hypercholesterolemia and familial
https://doi.org/10.1161/01.CIR.0000131511.50734.44
37